Text Size
61 studies found for:    THPO

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Recombinant Human Thrombopoietin (rhTPO) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
Conditions: Purpura;   Idiopathic Thrombocytopenic Purpura
Interventions: Drug: recombinant human thrombopoietin (rhTPO); dexamethasone;   Drug: Dexamethasone
2 Recruiting Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
Conditions: Purpura;   Idiopathic Thrombocytopenic Purpura
Interventions: Drug: recombinant human thrombopoietin (rhTPO); rituximab;   Drug: Dexamethasone
3 Completed Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy
Conditions: Germ Cell Tumors;   Hepatic Cancer;   Neuroblastoma;   Osteosarcoma;   Rhabdomyosarcoma
Intervention: Drug: Recombinant Human Thrombopoietin
4 Recruiting A Multicentre Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus Low-dose Rituximab in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）
Conditions: Purpura;   Idiopathic Thrombocytopenic Purpura
Interventions: Drug: rituximab; recombinant human thrombopoietin (rhTPO);   Drug: Rituximab
5 Completed An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
Conditions: Purpura, Thrombocytopenic, Idiopathic;   Immune Thrombocytopenic Purpura
Intervention:
6 Recruiting Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)
Conditions: Purpura;   Idiopathic Thrombocytopenic Purpura
Intervention: Drug: rhTPO in combination with Rituximab
7 Completed SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy
Conditions: Thrombocytopenia;   Thrombocytopaenia
Interventions: Drug: SB497115;   Other: Placebo
8 Recruiting Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics
Condition: Immune Thrombocytopenia Response to Thrombopoietin Mimetics
Intervention:
9 Completed Thrombopoietin Levels and Platelet Transfusion in Neonates
Condition: Thrombocytopenia
Intervention:
10 Recruiting A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Aplastic Anemia Patients With Immunosuppressive-Therapy Refractory Thrombocytopenia
Conditions: Anemia, Aplastic;   Anemia, Hypoplastic;   Thrombocytopenia
Interventions: Drug: Eltrombopag (Promacta);   Drug: Eltrombopag
11 Completed SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C
Conditions: Hepatitis C, Chronic;   Hepatitis C;   Thrombocytopenia
Interventions: Drug: SB497115;   Other: Placebo
12 Recruiting Efficacy and Safety of rHuTPO on Platelet Engraftment After Allo-HSCT
Conditions: Allogeneic Hematopoietic Stem Cell Transplantation;   Myeloablative;   Delayed Platelet Engraftment
Intervention: Drug: Recombinant Human Thrombopoietin
13 Recruiting A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)
Conditions: Myelodysplastic Syndromes;   Thrombocytopenia
Intervention: Drug: Eltrombopag
14 Recruiting Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Intervention:
15 Unknown † Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
Condition: Cancer
Interventions: Biological: filgrastim;   Biological: recombinant human thrombopoietin;   Drug: carboplatin;   Drug: etoposide;   Drug: ifosfamide
16 Unknown † Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: recombinant human thrombopoietin
17 Recruiting Eltrombopag for Moderate Aplastic Anemia
Conditions: Eltrombopag;   Aplastic Anemia;   Aplastic Anemia Treatment;   Moderate Aplastic Anemia;   Moderate Aplastic Anemia Treatment
Intervention: Drug: Eltrombopag
18 Not yet recruiting Low-dose Decitabine Versus Recombinant Human Thrombopoietin for the Treatment of Refractory Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Interventions: Drug: Decitabine;   Drug: rhTPO
19 Recruiting Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP
Conditions: Thrombocytopenia;   Immune Thrombocytopenia;   Idiopathic Thrombocytopenic Purpura
Intervention: Drug: rhTPO
20 Recruiting Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
Condition: Thrombocytopaenia
Interventions: Drug: Eltrombopag olamine;   Other: Placebo
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years